Sotyktu

head to head against clash football helmets fight combat
Favicon Fierce Biotech

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year.
Nick Paul Taylor Jun 11, 2026 7:00am
Bristol Myers Squibb

FDA expands label for BMS' Sotyktu to treat psoriatic arthritis

Mar 9, 2026 11:16am
Sotyktu

BMS puts discounted Sotyktu at the center of next DTC platform

Sep 25, 2025 11:01am
Sotyktu

Trial results enhance BMS bid for Sotyktu in psoriatic arthritis

Mar 10, 2025 8:38am
Takeda

JPM25: Takeda touts 6 pipeline assets with big sales potential

Jan 15, 2025 3:17pm
BMS

Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says

Dec 23, 2024 11:25am